IA
PFE icon

Icon Advisers’s Pfizer PFE Stock Holding History

Icon Advisers’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-54,492
Closed -$1.83M – 330
2018
Q1 		$1.83M Hold
54,492
– – 0.14% 150
2017
Q4 		$1.87M Sell
54,492
-76,731
-58% -$2.62M 0.13% 159
2017
Q3 		$4.45M Sell
131,223
-197,098
-60% -$6.33M 0.31% 107
2017
Q2 		$10.5M Sell
328,321
-87,693
-21% -$2.77M 0.73% 30
2017
Q1 		$13.5M Buy
416,014
+10,013
+2% +$316K 0.93% 16
2016
Q4 		$12.5M Buy
406,001
+307,874
+314% +$9.4M 0.85% 16
2016
Q3 		$3.15M Buy
98,127
+66,085
+206% +$2.21M 0.21% 155
2016
Q2 		$1.07M Buy
32,042
+4,849
+18% +$155K 0.07% 258
2016
Q1 		$765K Buy
+27,193
New +$777K 0.05% 251
2013
Q4 		– Sell
-159,154
Closed -$4.34M – 327
2013
Q3 		$4.34M Buy
+159,154
New +$4.33M 0.33% 72

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Icon Advisers's PFE Position: Q2 2018 in Review

Icon Advisers sold out of Pfizer (PFE) in Q2 2018, closing a stake of 54,492 shares — an estimated $1.83M sold.

Icon Advisers first reported a position in PFE in Q3 2013 and held it in 10 quarters. The position peaked at $13.5M in Q1 2017. 2,204 funds tracked by Wall St. Rank hold PFE as of Q2 2018.

  • Icon Advisers reported no remaining Pfizer position as of Q2 2018 after selling out during the quarter.
  • Icon Advisers sold 54,492 Pfizer shares in Q2 2018, an estimated $1.83M.
  • Icon Advisers first reported a position in Pfizer in Q3 2013 and held it in 10 quarters.
  • Icon Advisers's Pfizer position peaked at $13.5M in Q1 2017.
  • 2,204 funds tracked by Wall St. Rank held Pfizer as of Q2 2018.

Based on Icon Advisers's 13F filing for Q2 2018, filed 3 Aug 2018.